Professor Elisabeth Bendstrup (Aarhus University Hospital, Denmark) spoke with touchRESPIRATORY around the STARLINER study, assessing disease behaviour in ILD and the challenges associated with home-based assessments.
The abstract ‘STARLINER study, disease behaviour assessed by a wide range of parameters including patient-reported outcomes (PRO) results.’ (Presentation ID: 1207) was presented at ERS International Congress 2021, 5-8 September 2021.
Questions
- What were the aims, design and inclusion criteria of the STARLINER study? (0:18)
- Could you give us an overview of the study findings? (2:25)
- What technical challenges were experienced in the home-based assessments? (4:16)
- What were the conclusions of the investigators and what further studies are needed? (5:57)
Disclosures: Elisabeth Bendstrup has received grants or personal fees for talks, advisory board meetings, travel support for conferences and meetings from Boehringer Ingelheim, Roche, AStraZeneca, Galapagos, Bristol Myers Squibb in recent years. The study featured in the interview is fully financed by Roche.
Support:Â Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ERS 2021 (Virtual).
